非吸烟斯里兰卡成年人的慢性阻塞性肺病 (COPD);一个横截面研究
K D Gunasekera1, Wadl Amarasiri2, A R Wickremasinghe3
1Nawaloka Hospitals PLC, Colombo 2, Sri Lanka.
BMC research notes
|February 26, 2025
概括
在斯里兰卡的非吸烟成年人中,慢性阻塞性肺病 (COPD) 的患病率为5.3%. 生物质燃料的使用和被动吸烟显著增加了COPD风险,特别是在40岁以上的女性中.
科学领域:
- 肺部医学 肺部医学
- 流行病学 流行病学
- 环境健康 环境健康
背景情况:
- 慢性阻塞性肺病 (COPD) 是一个重要的全球健康问题.
- 在非吸烟者中评估COPD患病率对于了解疾病负担至关重要.
- 阻塞性肺病负担 (BOLD) 研究为此类评估提供了一个框架.
研究的目的:
- 为了确定斯里兰卡非吸烟成年人中COPD的患病率.
- 在这个人群中确定与COPD相关的风险因素.
- 为更广泛地了解阻塞性肺病提供数据.
主要方法:
- 在斯里兰卡进行的一项基于人口的研究,涉及非吸烟成年人.
- 螺旋测量用于诊断COPD.
- 统计分析,包括几率比率 (OR) 和95%信心区间 (CI),用于评估风险因素.
主要成果:
- 在非吸烟成年人中,COPD的患病率为5.3%.
- 40岁以上的女性和个人占COPD诊断患者的比例更高.
- 重要风险因素包括生物质燃料使用 (OR=1.339),被动吸烟 (OR=2.376) 和女性性别 (OR=1.353).
- 在用生物质/煤油时使用烟将COPD风险降低29%.
结论:
- 在斯里兰卡,COPD影响了相当多的非吸烟成年人.
- 生物质燃料造成的室内空气污染和被动吸烟是显著的风险因素.
- 改善通风 (烟) 等干预措施可以减轻COPD风险.
相关概念视频
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:22Chronic Obstructive Pulmonary Disease
1.1K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.7K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K